Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating activities
Net income	$ 3,108	$ 7,051
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	6,400	5,998
Amortization of deferred financing costs and debt discount	568	763
Loss recognized on impairment of assets held for sale	647
Stock-based compensation	2,024	1,700
Provision for losses on accounts receivable	163	208
Deferred income taxes	3,342	3,631
Earnout liability	3,814
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(45,403)	(36,867)
Inventories	(1,542)	(6,375)
Prepaid and other assets and prepaid income taxes	(423)	(2,145)
Accounts payable	(2,369)	(2,939)
Accrued expenses and other current liabilities	2,177	(5,429)
Deferred compensation	(156)	(156)
Benefit obligations and other long-term liabilities	928	(533)
Net cash used in operating activities	(26,722)	(35,093)
Investing activities
Capital expenditures	(1,747)	(1,083)
Proceeds from sale of equipment		80
Acquisition of Trynex	(26,734)
Net cash used in investing activities	(28,481)	(1,003)
Financing activities
Shares withheld on restricted stock vesting paid for employees' taxes	(160)
Dividends paid	(13,935)	(13,631)
Revolver borrowings	50,000	23,000
Repayment of long-term debt	(863)	(10,863)
Net cash provided by (used in) financing activities	35,042	(1,494)
Change in cash and cash equivalents	(20,161)	(37,590)
Cash and cash equivalents at beginning of period	24,136	39,432
Cash and cash equivalents at end of period	$ 3,975	$ 1,842